Bioxytran (BIXT) Other Operating Expenses (2013 - 2026)
Bioxytran's Other Operating Expenses came in at $210,000 for Q2 2026, up 676.4% from $27,048 a year earlier but down 85.9% from the prior quarter.
Powered by 
Analysis
Bioxytran (BIXT) Other Operating Expenses (2013 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Bioxytran reported Other Operating Expenses of $2.41 million, up 474.5% year-over-year; for FY2025, it was $740,280, down 21.5% from FY2024.
- Other Operating Expenses carries a five-year compound annual growth rate of 24.5% (FY2020 to FY2025).
- Going back by year, Other Operating Expenses was $943,229 in FY2024 (-24.4%), $1.25 million in FY2023 (+285.0%), $324,094 in FY2022 (-44.9%) and $587,987 in FY2021 (+137.2%).
- The five-year range for quarterly Other Operating Expenses is -$238,465 (Q4 2021) to $1.49 million (Q1 2026).
- Year-over-year, Other Operating Expenses increased in three of the last six quarters, with growth averaging 105.6%.
- The fastest year-over-year change in Other Operating Expenses over five years came in Q2 2026 (growth of 676.4%), and the weakest in Q1 2025 (a decline of 94.9%).
- Business Quant data shows BIXT's Other Operating Expenses at $1.49 million (Q1 2026), $369,486 (Q4 2025) and $336,874 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 210,000.00 |
| Mar 31, 2026 | 1.49 Mn |
| Dec 31, 2025 | 369,486.00 |
| Sep 30, 2025 | 336,874.00 |
| Jun 30, 2025 | 27,048.00 |
| Mar 31, 2025 | 21,872.00 |
| Dec 31, 2024 | 233,416.00 |
| Sep 30, 2024 | 137,133.00 |
| Jun 30, 2024 | 161,447.00 |
| Mar 31, 2024 | 431,232.00 |
| Dec 31, 2023 | -47,719.00 |
| Sep 30, 2023 | 436,558.00 |
| Jun 30, 2023 | 303,110.00 |
| Mar 31, 2023 | 23,600.00 |
| Dec 31, 2022 | 181,464.00 |
| Sep 30, 2022 | 73,507.00 |
| Jun 30, 2022 | 46,723.00 |
| Mar 31, 2022 | 43,120.00 |
| Dec 31, 2021 | -238,465.00 |
| Sep 30, 2021 | 844.00 |
API Access
Bioxytran Other Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-operating-expenses", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();